301207 Hualan Biological Vaccine Inc.
- 19.49
- +0.21+1.09%
Hualan Biological Vaccine Inc. News
Hualan Vaccine: 2024-048 Announcement on completion of share repurchase implementation and share changes
Hualan Vaccine: Progress Announcement on the Repurchase of the Company\'s Shares
Hualan Biological Vaccine Inc.: Announcement regarding the progress of repurchasing company shares.
Hualan Biological Vaccine Inc.: Announcement regarding the progress of repurchasing company shares.
Hualan Biological Vaccine Inc.: Announcement Regarding the First Share Buyback
Hualan Biological Vaccine Inc.: Announcement on the adjustment of the upper limit of the repurchase price after the implementation of the annual equity distribution in 2023.
Hualan Biological Vaccine Inc.: Repurchase report.
Hualan Biological Vaccine Inc.: Announcement on the shareholder holdings of the top ten shareholders and the top ten unrestricted shareholders regarding share repurchase matters.
Hualan Biological Vaccine Inc.: Announcement regarding the share repurchase plan of the company.
Hualan Biological Vaccine Inc.: Announcement of the implementation of equity distribution in 2023.
Hualan Biological Vaccine Inc.: Announcement on the Chairman's Proposal to Repurchase Company Shares
Hualan Biological Vaccine Inc.: Announcement on stock ownership results and stock listing for the first time granted by the 2022 Restricted Stock Incentive Plan for the first time
Hualan Biological Vaccine Inc.: Simplified equity change report (Morning 1 Qiming)
Hualan Biological Vaccine Inc.: Legal Opinion of Anhui Chengyi Law Firm on matters relating to Hualan Biovaccine Co., Ltd.'s 2022 Restricted Stock Incentive Plan granted part of the first vesting period, the fulfillment of ownership conditions and the abolition of some restricted shares (1)
Hualan Biological Vaccine Inc.: Announcement on the 2022 Restricted Stock Incentive Plan for the first time granting some of the achievements of the first vesting period
Hualan Biological Vaccine Inc.: Prompt announcement on changes in shareholders' equity
Hualan Biological Vaccine Inc.: Announcement on abolishing part of the 2022 Restricted Stock Incentive Plan and granting restricted stocks that have not yet been vested
Hualan Biological Vaccine Inc.: The Supervisory Board's review opinion on the company's 2022 restricted stock incentive plan granted part of the first vesting period list for the first time
Hualan Biological Vaccine Inc.: Announcement on the expiration of the shareholders' share reduction plan and the status of shareholders' holdings reduction
Hualan Vaccine: Plans for 2023 Profit Distribution
Analysis
Price Target
No Data
No Data